儿童患者异种移植伦理考量
随着异种移植进展,婴幼儿因机械循环支持选择有限、等待期死亡率高及免疫系统不成熟可能获益而被考虑为早期临床应用群体。本文讨论其生物学、感染与免疫学特殊考量及父母知情同意的伦理评估要点。
要点
- 婴幼儿机械循环支持选择有限且等待期死亡率高。
- 免疫系统不成熟可能带来异种移植潜在获益。
- 需评估生物学、感染、免疫学及父母同意等伦理问题。
核心结论
- 婴幼儿可考虑为异种移植早期临床应用群体,但需综合生物学、感染、免疫学及父母知情同意等伦理评估。
主要发现
- 婴幼儿机械循环支持选择有限、等待期死亡率高。
- 免疫系统不成熟可能带来异种移植潜在获益。
临床怎么用
- 对婴幼儿异种移植临床决策需纳入生物学、感染、免疫学及父母同意等伦理考量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
With recent advances in xenotransplantation, an increased initiative toward clinical applications in human recipients has evolved. Along with this trend, ethical concerns and considerations have been discussed. Infants and young children have been suggested as a group of patients for consideration of early clinical application given their limited mechanical circulatory support options, high waitlist mortality, and potential benefits of the immature immune system. However, there are also specific biological, infectious, and immunologic considerations and the unique aspects of obtaining consent from the parents that need to go into the ethical assessment and are discussed in this perspective.
引用
- Urschel S, Benden C, Fedson S, et al. Considerations of ethical aspects of xenotransplantation in pediatric patients. J Heart Lung Transplant. 2025. PMID: 40118308. doi:10.1016/j.healun.2025.03.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。